Reduced Diffusion Capacity in COVID-19 Survivors - PubMed (original) (raw)

Reduced Diffusion Capacity in COVID-19 Survivors

Raúl Méndez et al. Ann Am Thorac Soc. 2021 Jul.

No abstract available

PubMed Disclaimer

Similar articles

Cited by

References

    1. European Centre for Disease Prevention and Control. COVID-19 situation update worldwide. 2020 [accessed 2020 Dec 22]. Available from: https://www.ecdc.europa.eu/en/geographical-distribution-2019-ncov-cases.
    1. Mo X, Jian W, Su Z, Chen M, Peng H, Peng P, et al. Abnormal pulmonary function in COVID-19 patients at time of hospital discharge. Eur Respir J. 2020;55:2001217. - PMC - PubMed
    1. Frija-Masson J, Debray M-P, Gilbert M, Lescure F-X, Travert F, Borie R, et al. Functional characteristics of patients with SARS-CoV-2 pneumonia at 30 days post-infection. Eur Respir J. 2020;56:2001754. - PMC - PubMed
    1. Zhao YM, Shang YM, Song WB, Li QQ, Xie H, Xu QF, et al. Follow-up study of the pulmonary function and related physiological characteristics of COVID-19 survivors three months after recovery. EClinicalMedicine. 2020;25:100463. - PMC - PubMed
    1. Stanojevic S, Graham BL, Cooper BG, Thompson BR, Carter KW, Francis RW, et al. Global Lung Function Initiative TLCO working group; Global Lung Function Initiative (GLI) TLCO. Official ERS technical standards: Global Lung Function Initiative reference values for the carbon monoxide transfer factor for Caucasians. Eur Respir J. 2017;50:1700010. - PubMed

Publication types

MeSH terms

LinkOut - more resources